Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
16.78
-0.11 (-0.65%)
Aug 31, 2026, 10:06 AM EDT - Market open

IART Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-7.24-516.47-6.9467.74180.55169.08
Depreciation & Amortization
153.52151.83140.89123.51118.3119.84
Other Amortization
4.355.615.596.166.857.03
Loss (Gain) From Sale of Assets
0.730.491.50.78-7.46-39.56
Asset Writedown & Restructuring Costs
-511.3712.21--2.75
Stock-Based Compensation
22.4318.5824.3820.1427.7336.21
Other Operating Activities
-40.65-87.28-17.243.19-22.07-1.08
Change in Accounts Receivable
16.66-0.497.44.59-33.917.27
Change in Inventory
-30.54-46.76-28.15-59.77-29.125.37
Change in Accounts Payable
-5.5826.72-2.67-20.2317.3432.87
Change in Unearned Revenue
-0.343.43.540.134.270.03
Change in Other Net Operating Assets
-28-16.62-11.12-6.291.99-27.38
Operating Cash Flow
85.3350.38129.38139.96264.47312.43
Operating Cash Flow Growth
20.37%-61.06%-7.56%-47.08%-15.35%53.28%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-59.53-81.44-104.42-66.87-42.34-48.02
Sale of Property, Plant & Equipment
----11.150
Cash Acquisitions
---277.81--51.51-303.91
Divestitures
----23.96190.47
Sale (Purchase) of Intangibles
-14.2-14.2-9.95--4.74-0.06
Investment in Securities
-23.98-1.55.5-32.69--
Other Investing Activities
-10.92-10.92-4.135.384.910.08
Investing Cash Flow
-108.63-108.06-390.81-94.18-58.58-161.44

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-720.7486.5165.140.7525.5
Long-Term Debt Repaid
--669.89-187.13-110.6-148.55-125.5
Net Debt Issued (Repaid)
30.0750.81299.3754.5-107.8-100
Issuance of Common Stock
0.760.966.44.325.476.82
Repurchase of Common Stock
-1.93-2.92-55.98-280.86-149.62-4.8
Other Financing Activities
-7.33-20.52-11.92-7.88--0.25
Financing Cash Flow
21.5828.34237.86-229.93-251.95-98.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.7818.02-6.463.89-10.72-9.48
Net Cash Flow
-3.5-11.33-30.03-180.26-56.7943.28

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
25.8-31.0524.9673.09222.13264.41
Free Cash Flow Growth
---65.84%-67.09%-15.99%60.30%
Free Cash Flow Margin
1.57%-1.90%1.55%4.74%14.26%17.14%
Free Cash Flow Per Share
0.34-0.410.320.912.663.09
Levered Free Cash Flow
94.444.4690.1584.87165.64377.4
Unlevered Free Cash Flow
147.4792.77128.7110.82189.79401.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
81.481.464.444.342.243.2
Cash Income Tax Paid
17.217.222.723.635.949.5
Change in Working Capital
-47.8-33.74-31.01-81.57-39.4218.16
SEC Filings: 10-K · 10-Q